Borthwick Kathleen reported PASG

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001987062-26-000001

Machine-readable

Structured copy

Timestamps

Event (reported)

Jan 8, 2026

Published

Jan 12, 2026

Ingested by INSIDER

Nov 5, 04:23 UTC

Last re-read

Nov 5, 04:23 UTC

Extracted facts

Filer

Borthwick Kathleen

Role

CFO

Transaction

Option exerciseAs filed: “M”

Asset

Passage BIO, Inc. — Restricted Stock Unit

Ticker

PASG

Shares

5,000

Price per share

$0

Execution date (reported)

Jan 8, 2026

Owned after transaction

5,000 shares

Days from execution to publication

4

What this establishes

Borthwick Kathleen filed this Form 4 reporting a option exercise of PASG on Jan 8, 2026. It became public on Jan 12, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

CFO

Borthwick Kathleencik:0001987062

Issuer

Passage BIO, Inc.cik:0001787297

Revision history · 0

No field has changed since this record was first ingested.